Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002)
Clinical trial NCT02161510 · COMPLETED
Trial details
- NCT number
- NCT02161510
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-11-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.